Cullinan Therapeutics, Inc. reports

Company Who this page is about. 1 identity field
Location
Cambridge, MA
SEC filing record 1 source field
Fiscal year end
31 December
Cullinan Therapeutics, Inc. has filed 438 SEC EDGAR filings since 02 Nov 2020

SEC filing history

Showing 201-225 of 438 matching filings.

Per page
25
Current page
9
4

4

Filing date
29 Jun 2023
Reporting date
28 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39856

144 filing

Filing date
06 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 May 2023
Reporting date
23 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-270384

EFFECT filing

Filing date
18 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-270384

S-3/A

Filing date
11 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .